Pulmonary nodules/lung cancer requiring thoracoscopic lobectomy.
Conditions
Interventions
INB group: Intercostal nerve block (with 10ml of 0.25% ropivacaine):Intercostal nerve block (with 10ml of 0.25% ropivacaine)
INB+PNB group: INB (as above) + phrenic nerve block (10 mL of 0.25% ropivacaine,):INB (as above) + phrenic nerve block (10 mL of 0.25% ropivacaine,)
Sponsors
The Affiliated Hospital of Xuzhou Medical University
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: 1.Patients aged >18 years, regardless of gender; Diagnosed with lung cancer confirmed by pathological examination and scheduled to undergo thoracoscopic lobectomy; ASA I-III; Patients and their families have been informed and provided written informed consent. 2.Diagnosed with lung cancer confirmed by pathological examination and scheduled to undergo thoracoscopic lobectomy; 3.ASA I-III; 4.Patients and their families have been informed and provided written informed consent.
Exclusion criteria
Exclusion criteria: 1.Pre-existing chronic pain syndromes, cough variant asthma, acute exacerbation of chronic obstructive pulmonary disease, or other conditions that may affect the outcomes of this study. Presence of coagulation disorders, skin infections at the puncture site, or other related diseases. Allergy to the medications used in the study. Presence of mental illness or cognitive impairment that may hinder cooperation with the study. History of major thoracic surgery on the same side leading to altered anatomical structures.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Postoperative 12h VAS Pain Score (0-10) at Rest and during Cough; | — |
Secondary
| Measure | Time frame |
|---|---|
| QoR-15 Score (48 hours postoperatively); | — |
Countries
China
Contacts
Public ContactDunyi Qi
The Affiliated Hospital of Xuzhou Medical University
Outcome results
None listed